Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 3, 2006

Oncalis and ChemDiv Tackle Cancer-related Kinase Targets

  • Oncalis and ChemDiv entered into an R&D collaboration to discover candidates inhibiting receptor tyrosine kinase and other cancer-related targets. Oncalis will apply its yeast cell-based technology and develop biological assays, and ChemDiv will apply its medicinal chemistry and in vitro and in vivo biology services.

    ChemDiv provided the source for leads to the yeast-based screening platform that is now completely acquired by Oncalis, together with a high-throughput screening platform and IP rights on research projects.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »